225 related articles for article (PubMed ID: 33998412)
1. [Expert consensus regarding treatment of iron deficiency in stable and decompensated patients with heart failure].
Mareev YV; Gilarevsky SR; Begrambekova YL; Lopatin YM; Garganeeva AA; Duplyakov DV; Kobalava ZD; Golukhova EZ; Koziolova NA; Panov АV; Lelyavina ТА; Drapkina OM; Mareev VY
Kardiologiia; 2021 May; 61(4):73-78. PubMed ID: 33998412
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure.
Ponikowski P; Kirwan BA; Anker SD; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Haboubi T; Keren A; Khintibidze I; Kragten H; Martinez FA; McDonagh T; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Jankowska EA
Eur J Heart Fail; 2019 Dec; 21(12):1651-1658. PubMed ID: 31883356
[TBL] [Abstract][Full Text] [Related]
3. Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design.
Mentz RJ; Ambrosy AP; Ezekowitz JA; Lewis GD; Butler J; Wong YW; De Pasquale CG; Troughton RW; O'Meara E; Rockhold FW; Garg J; Samsky MD; Leloudis D; Dugan M; Mundy LM; Hernandez AF;
Circ Heart Fail; 2021 May; 14(5):e008100. PubMed ID: 34003690
[TBL] [Abstract][Full Text] [Related]
4. Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation.
McEwan P; Harrison C; Binnie R; Lewis RD; Cohen-Solal A; Lund LH; Ohlsson M; von Haehling S; Comin-Colet J; Pascual-Figal DA; Wächter S; Dorigotti F; de Arellano AR; Ponikowski P; Jankowska EA
Eur J Heart Fail; 2023 Mar; 25(3):389-398. PubMed ID: 36718652
[TBL] [Abstract][Full Text] [Related]
5. The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.
Jankowska EA; Kirwan BA; Kosiborod M; Butler J; Anker SD; McDonagh T; Dorobantu M; Drozdz J; Filippatos G; Keren A; Khintibidze I; Kragten H; Martinez FA; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parkhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Lewis BS; Comin-Colet J; von Haehling S; Cohen-Solal A; Danchin N; Doehner W; Dargie HJ; Motro M; Friede T; Fabien V; Dorigotti F; Pocock S; Ponikowski P
Eur Heart J; 2021 Aug; 42(31):3011-3020. PubMed ID: 34080008
[TBL] [Abstract][Full Text] [Related]
6. Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function.
Macdougall IC; Ponikowski P; Stack AG; Wheeler DC; Anker SD; Butler J; Filippatos G; Göhring UM; Kirwan BA; Kumpeson V; Metra M; Rosano G; Ruschitzka F; van der Meer P; Wächter S; Jankowska EA
Clin J Am Soc Nephrol; 2023 Sep; 18(9):1124-1134. PubMed ID: 37382961
[TBL] [Abstract][Full Text] [Related]
7. Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost-effectiveness analysis utilising AFFIRM-AHF.
McEwan P; Ponikowski P; Davis JA; Rosano G; Coats AJS; Dorigotti F; O'Sullivan D; Ramirez de Arellano A; Jankowska EA
Eur J Heart Fail; 2021 Oct; 23(10):1687-1697. PubMed ID: 34191394
[TBL] [Abstract][Full Text] [Related]
8. Role of Iron Therapy in Heart Failure: A Consensus Statement from India.
Chopra HK; Wander GS; Nair T; Ponde CK; Nanda NC; Narula J; Ray S; Venugopal K; Iyengar SS; Kasliwal RR; Chandra P; Prakash S; Bansal S; Rana DS; Kerkar P; Dasbiswas A; Sawhney J; Shanmungasundram S; Kumar V; Vijayalakshmi IB; Pancholia AK; Sharma V; Kapoor A; Swami OC; Isser HS; Rastogi V; Arora YK; Omar AK; Sathe S; Rajput R; Prabhakar D; Paul GJ; Jagia P; Malhotra P; Suryaprakash G; Mittal V; Jagia M; Jabir A; Mishra SS; Routray SN; Sinha AK; Bhargava M; Mahmood K; Bhatia M; Kalra P; Katyal VK; Tandon R; Grover R; Chhabra A; Shastry NR
J Assoc Physicians India; 2023 Mar; 71(3):11-12. PubMed ID: 37354511
[TBL] [Abstract][Full Text] [Related]
9. Iron Deficiency, Anemia, and Iron Supplementation in Patients With Heart Failure: A Population-Level Study.
Wahid M; Islam S; Sepehrvand N; Dover DC; McAlister FA; Kaul P; Ezekowitz JA
Circ Heart Fail; 2024 Apr; 17(4):e011351. PubMed ID: 38572652
[TBL] [Abstract][Full Text] [Related]
10. Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial.
Metra M; Jankowska EA; Pagnesi M; Anker SD; Butler J; Dorigotti F; Fabien V; Filippatos G; Kirwan BA; Macdougall IC; Rosano G; Ruschitzka F; Tomasoni D; van der Meer P; Ponikowski P;
Eur J Heart Fail; 2022 Oct; 24(10):1928-1939. PubMed ID: 35869741
[TBL] [Abstract][Full Text] [Related]
11. Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry.
Becher PM; Schrage B; Benson L; Fudim M; Corovic Cabrera C; Dahlström U; Rosano GMC; Jankowska EA; Anker SD; Lund LH; Savarese G
Eur J Heart Fail; 2021 Nov; 23(11):1844-1854. PubMed ID: 34476878
[TBL] [Abstract][Full Text] [Related]
12. Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions.
Cunha GJL; Rocha BML; Menezes Falcão L
Eur J Intern Med; 2018 Jun; 52():1-7. PubMed ID: 29680173
[TBL] [Abstract][Full Text] [Related]
13. Ferric carboxymaltose in patients with heart failure and iron deficiency.
Anker SD; Comin Colet J; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Bart B; Banasiak W; Niegowska J; Kirwan BA; Mori C; von Eisenhart Rothe B; Pocock SJ; Poole-Wilson PA; Ponikowski P;
N Engl J Med; 2009 Dec; 361(25):2436-48. PubMed ID: 19920054
[TBL] [Abstract][Full Text] [Related]
14. Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence.
Gonzalez-Costello J; Cainzos-Achirica M; Lupón J; Farré N; Moliner-Borja P; Enjuanes C; de Antonio M; Fuentes L; Díez-López C; Bayés-Genis A; Manito N; Pujol R; Comin-Colet J
Eur J Intern Med; 2020 Oct; 80():91-98. PubMed ID: 32439287
[TBL] [Abstract][Full Text] [Related]
15. Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction.
López-Vilella R; Lozano-Edo S; Arenas Martín P; Jover-Pastor P; Ezzitouny M; Sorolla Romero J; Calvo Asensio M; Martínez-Solé J; Guerrero Cervera B; Sánchez Martínez JC; Donoso Trenado V; Sánchez-Lázaro I; Martinez Dolz L; Almenar Bonet L
ESC Heart Fail; 2022 Feb; 9(1):133-145. PubMed ID: 34964300
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?
Tkaczyszyn M; Fudim M; Ponikowski P; Biegus J
Curr Heart Fail Rep; 2023 Aug; 20(4):300-307. PubMed ID: 37428429
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis.
Ponikowski P; Mentz RJ; Hernandez AF; Butler J; Khan MS; van Veldhuisen DJ; Roubert B; Blackman N; Friede T; Jankowska EA; Anker SD
Eur Heart J; 2023 Dec; 44(48):5077-5091. PubMed ID: 37632415
[TBL] [Abstract][Full Text] [Related]
18. Budget impact of ferric carboxymaltose treatment in patients with chronic heart failure and iron deficiency in Spain.
Delgado JF; Oliva J; González-Franco Á; Cepeda JM; García-García JÁ; González-Domínguez A; Garcia-Casanovas A; Jiménez Merino S; Comín-Colet J
J Med Econ; 2020 Dec; 23(12):1418-1424. PubMed ID: 33073660
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic impact of ferric carboxymaltose treatment for iron deficiency in patients stabilized following acute heart failure: a multinational study.
McEwan P; Ponikowski P; Shiri T; Rosano GMC; Coats AJS; Dorigotti F; Ramirez de Arellano A; Jankowska EA
J Med Econ; 2023; 26(1):51-60. PubMed ID: 36476095
[TBL] [Abstract][Full Text] [Related]
20. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.
Anker SD; Kirwan BA; van Veldhuisen DJ; Filippatos G; Comin-Colet J; Ruschitzka F; Lüscher TF; Arutyunov GP; Motro M; Mori C; Roubert B; Pocock SJ; Ponikowski P
Eur J Heart Fail; 2018 Jan; 20(1):125-133. PubMed ID: 28436136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
